Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma

被引:22
作者
Albarqi, Hassan A. [1 ]
Garg, Anuj [2 ]
Ahmad, Mohammad Zaki [1 ]
Alqahtani, Abdulsalam A. [1 ]
Walbi, Ismail A. [3 ]
Ahmad, Javed [1 ]
机构
[1] Najran Univ, Coll Pharm, Dept Pharmaceut, Najran 11001, Saudi Arabia
[2] GLA Univ, Inst Pharmaceut Res, Mathura 281406, India
[3] Najran Univ, Coll Pharm, Dept Clin Pharm, Najran 11001, Saudi Arabia
关键词
glaucoma; chitosan; nanoparticles; mucoadhesion; ocular bioavailability; therapeutic efficacy; DRUG-DELIVERY; IN-VITRO; LECITHIN/CHITOSAN NANOPARTICLES; TETRANDRINE DELIVERY; LIPID NANOPARTICLES; HYALURONIC-ACID; VIVO; RELEASE; DEACETYLATION; OPTIMIZATION;
D O I
10.3390/pharmaceutics15020681
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glaucoma is a degenerative, chronic ocular disease that causes irreversible vision loss. The major symptom of glaucoma is high intraocular pressure, which happens when the flow of aqueous humor between the front and back of the eye is blocked. Glaucoma therapy is challenging because of the low bioavailability of drugs from conventional ocular drug delivery systems such as eye drops, ointments, and gels. The low bioavailability of antiglaucoma agents could be due to the precorneal and corneal barriers as well as the low biopharmaceutical attributes of the drugs. These limitations can be overcome by employing nanoparticulate drug delivery systems. Over the last decade, there has been a lot of interest in chitosan-based nanoparticulate systems to overcome the limitations (such as poor residence time, low corneal permeability, etc.) associated with conventional ocular pharmaceutical products. Therefore, the main aim of the present manuscript is to review the recent research work involving the chitosan-based nanoparticulate system to treat glaucoma. It discusses the significance of the chitosan-based nanoparticulate system, which provides mucoadhesion to improve the residence time of drugs and their ocular bioavailability. Furthermore, different types of chitosan-based nanoparticulate systems are also discussed, namely nanoparticles of chitosan core only, nanoparticles coated with chitosan, and hybrid nanoparticles of chitosan. The manuscript also provides a critical analysis of contemporary research related to the impact of this chitosan-based nanomedicine on the corneal permeability, ocular bioavailability, and therapeutic performance of loaded antiglaucoma agents.
引用
收藏
页数:18
相关论文
共 84 条
[1]   Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study [J].
Abdelmonem, Rehab ;
Elhabal, Sammar E. ;
Abdelmalak, Nevine S. ;
El-Nabarawi, Mohamed A. ;
Teaima, Mahmoud H. .
PHARMACEUTICS, 2021, 13 (02) :1-20
[2]   Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration [J].
Abruzzo, A. ;
Giordani, B. ;
Miti, A. ;
Vitali, B. ;
Zuccheri, G. ;
Cerchiara, T. ;
Luppi, B. ;
Bigucci, F. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 606
[3]   The molecular basis of retinal ganglion cell death in glaucoma [J].
Almasieh, Mohammadali ;
Wilson, Ariel M. ;
Morquette, Barbara ;
Vargas, Jorge Luis Cueva ;
Di Polo, Adriana .
PROGRESS IN RETINAL AND EYE RESEARCH, 2012, 31 (02) :152-181
[4]   Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases [J].
Bachu, Rinda Devi ;
Chowdhury, Pallabitha ;
Al-Saedi, Zahraa H. F. ;
Karla, Pradeep K. ;
Boddu, Sai H. S. .
PHARMACEUTICS, 2018, 10 (01)
[5]   Novel Metoprolol-Loaded Chitosan-Coated Deformable Liposomes in Thermosensitive In Situ Gels for the Management of Glaucoma: A Repurposing Approach [J].
Badran, Mohamed M. ;
Alomrani, Abdullah H. ;
Almomen, Aliyah ;
Bin Jardan, Yousef A. ;
Abou El Ela, Amal El Sayeh .
GELS, 2022, 8 (10)
[6]  
BENSINGER R, 1976, INVEST OPHTH VISUAL, V15, P1008
[7]   Chitosan-based drug delivery systems [J].
Bernkop-Schnuerch, Andreas ;
Duennhaupt, Sarah .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) :463-469
[8]   Principles of nanoparticle design for overcoming biological barriers to drug delivery [J].
Blanco, Elvin ;
Shen, Haifa ;
Ferrari, Mauro .
NATURE BIOTECHNOLOGY, 2015, 33 (09) :941-951
[9]   Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan [J].
Burhan, Ayah Mohammad ;
Klahan, Butsabarat ;
Cummins, Wayne ;
Andres-Guerrero, Vanessa ;
Byrne, Mark E. ;
O'Reilly, Niall J. ;
Chauhan, Anuj ;
Fitzhenry, Laurence ;
Hughes, Helen .
PHARMACEUTICS, 2021, 13 (10)
[10]  
Buse J, 2010, NANOMEDICINE-UK, V5, P1237, DOI [10.2217/nnm.10.107, 10.2217/NNM.10.107]